Why I no longer consult for drug companies

Culture, Medicine and Psychiatry

Volumn 32, Issue 1, 2008, Pages 4-10

  Whitehouse, Peter J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG TOXICITY; ETHICS; HUMAN; MARKETING; PATIENT REFERRAL; POLLUTION; UNITED STATES;

ALZHEIMER DISEASE; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG TOXICITY; ENVIRONMENTAL POLLUTION; HUMANS; MARKETING; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 40149107408     PISSN: 0165005X     EISSN: 1573076X     Source Type: Journal    
DOI: 10.1007/s11013-007-9075-x     Document Type: Article

References (4)

1. Gaines, Atwood D., and Peter J. Whitehouse 2006 Building a Mystery: Alzheimer Disease, Mild Cognitive Impairment and Beyond. Philosophy Psychiatry and Psychology 13(1): 61-74
2. Whitehouse, Peter J. 1997 The International Working Group for Harmonization of Dementia Drug Guidelines: Past, Present, and Future. Alzheimer Disease and Associated Disorders 11(Suppl 3): 2-5
3. Whitehouse, Peter J. 1999 Editorial: Interesting Conflicts and Conflicting Interests. Journal of the American Geriatric Society 47: 1-3
4. Whitehouse, Peter J., Atwood D. Gaines, Heather Lindstrom, and Janice Graham (2005) Dementia in the Anthropological Gaze: Contributions to the Understanding of Dementia. The Lancet Neurology 4: 320-326